Exploring structural requirements of leads for improving activity and selectivity against CDK5/p25 in Alzheimer's disease: An in silico approach

RSC Advances

Volumn 4, Issue 13, 2014, Pages 6702-6709

  Ambure, Pravin ^a   Roy, Kunal ^a,b  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SITE RESIDUES; ALZHEIMER'S DISEASE; CONGENERIC SERIES; NEUROFIBRILLARY TANGLES; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; RELIABILITY AND ROBUSTNESS; STRUCTURAL FEATURE; STRUCTURAL REQUIREMENTS;

ENZYMES; MOLECULAR GRAPHICS; NEURODEGENERATIVE DISEASES; TOXIC MATERIALS;

COMPUTATIONAL CHEMISTRY;

EID: 84892592182     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c3ra46861e     Document Type: Article

References (27)

1. S. E. Arnold B. T. Hyman J. Flory A. R. Damasio G. W. Van Hoesen The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease Cereb. Cortex 1991 1 103 116
2. G. N. Patrick L. Zukerberg M. Nikolic S. de La Monte P. Dikkes L.-H. Tsai Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 1999 402 615 622
3. J. Kuret G. S. Johnson D. Cha E. R. Christenson A. J. DeMaggio M. F. Hoekstra Casein Kinase 1 Is Tightly Associated with Paired-Helical Filaments Isolated from Alzheimer's Disease Brain J. Neurochem. 1997 69 2506 2515
4. D. P. Hanger K. Hughes J. R. Woodgett J.-P. Brion B. H. Anderton Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase Neurosci. Lett. 1992 147 58 62
5. M. Otyepka B. Iveta K. Zdeněk K. Jaroslav Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics J. Biol. Chem. 2006 281 7271 7281
6. D. O. Morgan Cyclin-dependent kinases: engines, clocks, and microprocessors Annu. Rev. Cell Dev. Biol. 1997 13 261 291
7. M. Lee Y. T. Kwon M. Li J. Peng R. M. Friedlander L.-H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 2000 405 360 364
8. J. C. Cruz L.-H. Tsai A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease Curr. Opin. Neurobiol. 2004 14 390 394
9. J. Sridhar N. Akula N. Pattabiraman Selectivity and potency of cyclin-dependent kinase inhibitors AAPS J. 2006 8 E204 E221
10. M. R. Shiradkar K. C. Akula V. Dasari V. Baru B. Chiningiri S. Gandhi R. Kaur Clubbed thiazoles by MAOS: a novel approach to cyclin-dependent kinase 5/p25 inhibitors as a potential treatment for Alzheimer's disease Bioorg. Med. Chem. 2007 15 2601 2610
11. M. Shiradkar J. Thomas V. Kanase R. Dighe Studying synergism of methyl linked cyclohexyl thiophenes with triazole: Synthesis and their cdk5/p25 inhibition activity Eur. J. Med. Chem. 2011 46 2066 2074
12. ChemDraw Ultra 5.0, Cambridge Soft Corporation, Cambridge, USA, 1999
13. Cerius2 Version 4.10., Accelrys, Inc., San Diego, CA, 2005
14. C. W. Yap PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints J. Comput. Chem. 2011 32 1466 1474
15. R. Todeschini, V. Consonni, A. Mauri and M. Pavan, DRAGON-Software for the calculation of molecular descriptors version 6, 2004
16. J. T. Leonard K. Roy On selection of training and test sets for the development of predictive QSAR models QSAR Comb. Sci. 2006 25 235 251
17. P. Geladi B. R. Kowalski Partial least-squares regression: a tutorial Anal. Chim. Acta 1986 185 1 17
18. D. Rogers A. J. Hopfinger Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships J. Chem. Inf. Comput. Sci. 1994 34 854 866
19. K. Roy P. Chakraborty I. Mitra P. K. Ojha S. Kar R. N. Das Some case studies on application of rm2 metrics for judging quality of quantitative structure-activity relationship predictions: Emphasis on scaling of response data J. Comput. Chem. 2013 34 1071 1082
20. I. Mitra A. Saha K. Roy Exploring quantitative structure-activity relationship studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants Mol. Simul. 2010 36 1067 1079
21. A. Golbraikh A. Tropsha Beware of q2! J. Mol. Graphics Modell. 2002 20 269 276
22. A. Tropsha Best practices for QSAR model development, validation, and exploitation Mol. Inf. 2010 29 476 488
23. Glide, version 6.0, Schrödinger, LLC, New York, NY, 2013
24. J. Malmstrom J. Viklund C. Slivo A. Costa M. Maudet C. Sandelin G. Hiller L.-L. Olsson A. Aagaard S. Geschwindner Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors Bioorg. Med. Chem. Lett. 2012 12 5919 5923
25. N. M. O'Boyle M. Banck C. A. James C. Morley T. Vandermeersch G. R. Hutchison Open Babel: An open chemical toolbox J. Cheminf. 2011 3 1 14
26. M. Mapelli L. Massimiliano C. Crovace M. A. Seeliger L. Tsai L. Meijer A. Musacchio Mechanism of CDK5/p25 Binding by CDK Inhibitors J. Med. Chem. 2005 48 671 679
27. W. Wang X. Cao X. Zhu Y. Gu Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5 J. Mol. Model. 2013 19 2635 2645